NORMAN, OK – In a significant advancement for cancer research, scientists at the University of Oklahoma (OU)...
New Drug Candidate Demonstrates Robust Clinical Improvement in Acute Schizophrenia Patients, Outperforming Standard of Care in Key...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
By Delilah Alvarado Published October 12, 2026 In a significant development for the treatment of autoimmune disorders,...
The integration of artificial intelligence (AI) into medical technology has moved beyond the realm of speculative innovation...
Age-related hearing loss, often dismissed as an inevitable consequence of the human aging process, is undergoing a...
Published October 12, 2026 In an era defined by high-intensity interval training (HIIT) and the pursuit of...
Introduction: A Legacy of Compassion In the tapestry of the LGBTQ+ rights movement, the true strength of...
The landscape of oncology is perpetually shifting, yet few areas have seen as rapid an evolution as...
For many patients, the end of active breast cancer treatment—the final infusion, the last radiation session, or...
